摘要
脓毒症是重症监护病房内的常见急危重症。近年来人们逐步解释了连续性肾脏替代治疗降低脓毒症患者死亡率的机制,并进行了相关临床研究。在连续性肾脏替代治疗飞速发展的基础上高容量血液滤过应运而生,在临床得到了广泛应用,但关于高容量血液滤过的优缺点和治疗剂量还存在争议。目前对于脓毒症的高容量血液滤过治疗,推荐治疗剂量具体化、流量个体化的临床治疗思路。
Sepsis is a common acute and intensive severe in intensive care unit. In recent years, people gradually explain the continuous renal replacement therapy to reduce the mortality rate of patients with sepsis mechanism and related clinical research. On the basis of the rapid development of continuous renal replacement therapy high-volume hemofihration emerged. High-volume hemofiltration has been widely used in clinical practice, but still controversial about the advantages and disadvantages of the high-volume hem0filtra- tion treatment. For high-volume hemofihration treatment of sepsis, the recommended therapeutic dose specific, and clinical treatment flow should be individualized.
出处
《实用医院临床杂志》
2012年第6期5-8,共4页
Practical Journal of Clinical Medicine